Kinetiko Energy (ASX:KKO) Announces Q4 2024 Activities Report
Kinetiko Energy (ASX:KKO) reports strong financials and progress in gas production testing for Q4 2024.
Kinetiko Energy (ASX:KKO) reports strong financials and progress in gas production testing for Q4 2024.
Chimeric Therapeutics (ASX:CHM) advances clinical trials, secures $5M in funding, and appoints Dr Rebecca McQualter as CEO in Q4 report.
Structural Monitoring Systems Plc (ASX:SMN) secures $8.7M in capital and boosts sales by $2M, signaling strong growth and financial stability.
Arovella Therapeutics (ASX:ALA) secures $20 million placement, fully funding Phase 1 trials for ALA-101 and advancing its cancer therapy pipeline.
Blue Energy Limited (ASX:BLU) releases Q4 2024 report highlighting ongoing production testing, financial stability, and progress in legal and exploration activities.
Lincoln Minerals Limited (ASX:LML) announces December 2024 quarterly activities, focusing on project advancements and cost reduction strategies.
Andromeda Metals (ASX:ADN) reports Q4 progress on the Great White Project, highlighting funding advancements and government tax incentives.
Peninsula Energy Limited (ASX:PEN) releases its quarterly cash flow report, detailing cash outflows and plans for future funding.
Opthea Limited (ASX:OPT) releases Q2 FY25 Activity Report, detailing advancements in Phase 3 trials and financial developments including a R&D tax incentive.
Emperor Energy (ASX:EMP) releases its December 2024 quarterly report, highlighting share placement and progress on the Judith-2 Well project.